JP2017536397A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017536397A5 JP2017536397A5 JP2017529401A JP2017529401A JP2017536397A5 JP 2017536397 A5 JP2017536397 A5 JP 2017536397A5 JP 2017529401 A JP2017529401 A JP 2017529401A JP 2017529401 A JP2017529401 A JP 2017529401A JP 2017536397 A5 JP2017536397 A5 JP 2017536397A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- use according
- pancreatic
- fibrosis
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462086945P | 2014-12-03 | 2014-12-03 | |
| US62/086,945 | 2014-12-03 | ||
| PCT/US2015/063475 WO2016090021A1 (en) | 2014-12-03 | 2015-12-02 | Methods of treating fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017536397A JP2017536397A (ja) | 2017-12-07 |
| JP2017536397A5 true JP2017536397A5 (enExample) | 2019-01-31 |
Family
ID=56092404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017529401A Pending JP2017536397A (ja) | 2014-12-03 | 2015-12-02 | 線維症の治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9844552B2 (enExample) |
| EP (1) | EP3226864A4 (enExample) |
| JP (1) | JP2017536397A (enExample) |
| CN (1) | CN106999482A (enExample) |
| AR (1) | AR102871A1 (enExample) |
| AU (1) | AU2015358503A1 (enExample) |
| BR (1) | BR112017011897A2 (enExample) |
| CA (1) | CA2968866A1 (enExample) |
| HK (1) | HK1244692A1 (enExample) |
| MX (1) | MX2017007245A (enExample) |
| TW (2) | TW201740953A (enExample) |
| WO (1) | WO2016090021A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014339815B2 (en) | 2013-10-25 | 2020-03-26 | Pharmacyclics Llc | Methods of treating and preventing graft versus host disease |
| AR102871A1 (es) | 2014-12-03 | 2017-03-29 | Pharmacyclics Llc | Métodos de tratamiento de fibrosis |
| CZ2017787A3 (cs) | 2017-12-08 | 2019-06-19 | Zentiva, K.S. | Farmaceutické kompozice obsahující ibrutinib |
| CN113694187A (zh) * | 2021-07-20 | 2021-11-26 | 上海市东方医院（同济大学附属东方医院） | 一种用于抑制心肌纤维化的药物组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1934185A1 (en) * | 2005-08-12 | 2008-06-25 | Synta Pharmaceuticals Corporation | Pyrazole compounds that modulate hsp90 activity |
| PL2526933T3 (pl) | 2006-09-22 | 2015-08-31 | Pharmacyclics Llc | Inhibitory kinazy tyrozynowej Brutona |
| ES2660418T3 (es) | 2008-07-16 | 2018-03-22 | Pharmacyclics Llc | Inhibidores de la tirosina quinasa de Bruton para el tratamiento de tumores sólidos |
| US9371567B2 (en) * | 2010-04-19 | 2016-06-21 | The Translational Genomics Research Institute | Methods and kits to predict therapeutic outcome of BTK inhibitors |
| CN103732596B (zh) * | 2011-07-08 | 2016-06-01 | 诺华股份有限公司 | 吡咯并嘧啶衍生物 |
| EP2548877A1 (en) * | 2011-07-19 | 2013-01-23 | MSD Oss B.V. | 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| ES2709509T3 (es) | 2013-08-12 | 2019-04-16 | Pharmacyclics Llc | Procedimientos para el tratamiento de cáncer amplificado por HER2 |
| AU2014339815B2 (en) | 2013-10-25 | 2020-03-26 | Pharmacyclics Llc | Methods of treating and preventing graft versus host disease |
| EP3076975A4 (en) | 2013-12-02 | 2017-05-03 | Pharmacyclics, LLC | Methods of treating and preventing alloantibody driven chronic graft versus host disease |
| RU2646758C2 (ru) | 2013-12-05 | 2018-03-07 | Ф. Хоффманн-Ля Рош Аг | Гетероарил пиридоны и азапиридоны с электрофильной функциональностью |
| WO2015149056A1 (en) | 2014-03-28 | 2015-10-01 | Board Of Regents, The University Of Texas System | Inhibition of bruton's tyrosine kinase (btk) in the lung to treat severe lung inflammation and lung injury |
| AR102871A1 (es) | 2014-12-03 | 2017-03-29 | Pharmacyclics Llc | Métodos de tratamiento de fibrosis |
-
2015
- 2015-12-01 AR ARP150103925A patent/AR102871A1/es unknown
- 2015-12-02 HK HK18104208.0A patent/HK1244692A1/zh unknown
- 2015-12-02 TW TW106106688A patent/TW201740953A/zh unknown
- 2015-12-02 CN CN201580065663.4A patent/CN106999482A/zh active Pending
- 2015-12-02 BR BR112017011897-1A patent/BR112017011897A2/pt not_active Application Discontinuation
- 2015-12-02 CA CA2968866A patent/CA2968866A1/en not_active Abandoned
- 2015-12-02 WO PCT/US2015/063475 patent/WO2016090021A1/en not_active Ceased
- 2015-12-02 JP JP2017529401A patent/JP2017536397A/ja active Pending
- 2015-12-02 MX MX2017007245A patent/MX2017007245A/es unknown
- 2015-12-02 TW TW104140382A patent/TW201625257A/zh unknown
- 2015-12-02 US US14/957,294 patent/US9844552B2/en active Active
- 2015-12-02 AU AU2015358503A patent/AU2015358503A1/en not_active Abandoned
- 2015-12-02 EP EP15864946.7A patent/EP3226864A4/en not_active Withdrawn
-
2017
- 2017-12-08 US US15/836,482 patent/US10226466B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523397A5 (enExample) | ||
| JP2020511414A5 (enExample) | ||
| JP2017536397A5 (enExample) | ||
| JP2016528162A5 (enExample) | ||
| JP2015007118A5 (enExample) | ||
| JP2015511609A5 (enExample) | ||
| JP2020513745A5 (enExample) | ||
| JP2013534535A5 (enExample) | ||
| JP2015528491A5 (enExample) | ||
| NZ598145A (en) | Folate-targeted diagnostics and treatment | |
| JP2016519107A5 (enExample) | ||
| JP2021105005A5 (enExample) | ||
| JP2013544892A5 (enExample) | ||
| EA202090139A1 (ru) | Контрастный агент для компьютерной томографии | |
| RU2014141934A (ru) | Комбинация производного 6-оксо-1,6-дигидро-пиридазина, которая обладает противораковым действием с другими противоопухолевыми соединениями | |
| JP2013536236A5 (enExample) | ||
| RU2017124371A (ru) | Комбинация производного 6-оксо-1,6-дигидро-пиридазина, обладающего противораковой активностью, с производным хиназолина | |
| RU2015139515A (ru) | Комбинированное лечение | |
| JP2020521786A5 (enExample) | ||
| RU2015117550A (ru) | Комбинация производного 6-оксо-1,6-дигидро-пиридазина, имеющего противораковую активность, с мек ингибитором | |
| JP2016500649A5 (enExample) | ||
| RU2016132400A (ru) | Комбинация производного 6-оксо-1,6-дигидро-пиридазина, имеющего противораковую активность, с гефитинибом | |
| JP2014118361A5 (enExample) | ||
| RU2460461C1 (ru) | Методика проведения ирригоскопии при стенозирующем варианте опухолевого поражения ободочной кишки | |
| RU2007111754A (ru) | Применение мидостаурина для лечения желудочно-кишечных стромальных опухолей |